MediciNova, Inc. , a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
Medicinova stock last closed at $1.96, up 0% from the previous day, and has decreased 12.89% in one year. It has underperformed other stocks in the Biotechnology industry by 0.05 percentage points. Medicinova stock is currently +75% from its 52-week low of $1.12, and -17.65% from its 52-week high of $2.38.
At the moment, there are 49.05M shares of MNOV outstanding. The market capitalization of MNOV is $96.13M. In the past 24 hours, 36,933 MNOV shares were traded.
You need an online brokerage account to access the NASDAQ market and buy MNOV stock.
We believe that eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountNow that you've selected your brokerage, you'll need to fill out some personal information so you can buy MNOV today.
Now that you've finished signing up on the best app for stock investing, you need to deposit funds:
Watch the video below to see the process of depositing money into your new investment account.
Once you have figured out the best place to buy Medicinova stock, it's very important to research their stock prior to buying, so you truly comprehend the risk and upside.
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on MNOV's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge MNOV's true value.
Using relative valuations metrics:
You can do more valuation research on MNOV's stock here.
You can dig deeper into what analysts are forecasting on the Medicinova stock forecast page.
Last year, MNOV revenue was $1.00M. Over the last three year, MNOV's revenue has grown by -90.86% per year. This was slower than the Biotechnology industry average of 55.92%.
You can analyze MNOV's earnings and revenue performance here.
Over the last 12 months, insiders at MNOV have not bought or sold any shares.
Research more about who owns MNOV shares here.
No, Medicinova doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two primary types of orders:
Click the Open button and your broker will execute the order.
If you need more assistance investing in stocks on eToro, watch the helpful video below:
Now that you own some MNOV stock, you'll want to keep up with your new company.
Add MNOV to a watchlist to monitor your MNOV stock.
To reiterate, here are the 6 steps to buy Medicinova stock:
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Medicinova, click the button below.